Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Request for Sample Pages

Published Date : 3 October 2011

Pages : 80

Add to Cart - Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Summary

Company , the leading business intelligence provider, has released its latest research, “Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future” which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by Company ’s team of industry experts. The report provides an in-depth analysis of the contraceptives most commonly used, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. The report also examines usage patterns for oral, topical and injectable contraceptives treatment. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by Company ’s team of industry experts.

Company analysis shows that revenues are projected to increase from $15.5 billion in 2010 to $19.2 in 2017 at a CAGR of 3.1%. Prescription and OTC contraceptives held an 82% and 18% market share, respectively, in 2010. The intrauterine devices market was valued at $1,370.4m in 2010 and revenues are projected to increase to $1,398.1m in 2017, at a CAGR of 0.3%. However, revenues are expected to decline in 2015 due to the patent expiry of Mirena and the availability of low cost hormonal intrauterine devices. Strategic consolidations through acquisition accounted for 31% of M&A deals.

Scope

The report analyzes the market characterization, pipeline analysis and key M&A trends for oral, topical and injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.
Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan.
Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2002-2010, with forecasts to 2017.
Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and annual cost of usage.
Key drivers and restraints that have had a significant impact on the market.
The competitive landscape of the contraceptives market, which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.
Key M&A activities and licensing agreements that took place from 2005-2011 in the contraceptives market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

Align your product portfolio to markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
Devise a more tailored country strategy through understanding of key drivers and barriers in the contraceptives market.
Develop key strategic initiatives by understanding the key focus areas of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Additional Information

Company , the leading business intelligence provider, has released its latest research, “Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future” which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by Company ’s team of industry experts. The report provides an in-depth analysis of the most commonly used contraceptives, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. It also examines treatment usage patterns of oral, topical and injectable contraceptives. In addition, the report also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape. Finally, the report also includes analysis on mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by Company ’s team of industry experts.

High Growth Rate and Increasing Awareness Have Made Contraceptive Market Attractive

Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002 - 2017

Source: Company , Centre for Disease Prevention and Control (CDC), Food and Drug Administration (FDA), Pubmed, Company Websites, Annual Reports

The global hormonal contraceptive market is a fast growing market, with oral contraceptives considered to be the most common method of avoiding unplanned pregnancies. In 2010, the global contraceptives market was valued at $15.5 billion and is forecast to grow to $19.2 billion by 2017, which represents a growth rate of 3.1% from 2010 - 2017. According to a report by the Guttmacher Institute, the number of women who require publicly funded contraceptives increased by one million from 2001 - 2004. An increase in the number of women who require publicly funded contraception indicates an increasing awareness among women of contraceptive methods. The use of contraceptive devices such as condoms, intrauterine devices and vaginal rings will increase market value. Increasing awareness will accelerate growth in the contraceptive market by 2017. As a result, market growth will continue and this will attract the attention of pharmaceutical companies.

Strong Pipeline and the Entry of New Companies Will Intensify Competition

Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011

Source: Company , Company Websites, Clinicaltrials.gov

The contraceptives market has a strong pipeline base which supports growth in the market and attracts many pharmaceutical and biotechnological companies. Major pharmaceutical companies such as Teva, Watson, Bayer and Merck have active contraceptive pipelines. One of the main activities in the market at present is the development of generic versions of off-patent drugs. The entry of generic versions will strengthen the oral contraceptive market and lead to further growth in the hormonal contraceptives market. Of all pipeline molecules, 72% are in Phase II and Phase III of clinical trials. In the forecast period, the CSD500, a condom manufactured by Futura Medical and licensed to Reckitt and Benckiser, will strengthen the condom market. Additionally, the entry of new companies is set to intensify competition in the condom market. Also, the presence of a highly active pipeline in this market indicates strong competition in the future.

Strategic Consolidations Have Led to the Entry of New Companies in the Contraceptives Market

In the past seven years, many pharmaceutical companies have improved their product portfolios in the contraceptives market. This is primarily due to a number of prominent deals which aimed to introduce new products to the market with better efficacy and safety profiles. The acquisition of Schering AG by Bayer, Andrx by Watson and Mirecette Contraceptives by Barr Pharmaceuticals are the main acquisitions that recently took place in the contraceptives market.

These strategic consolidations will help acquirer and licensee companies to diversify their product portfolios through entry in the contraceptives market, which will in turn strengthen the contraceptives market. These consolidations will also help companies generate additional revenue and increase total revenue in the global contraceptives market.

Table of Contents :

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Contraceptives Market to 2017- Introduction
2.1 GBI Research Report Guidance
3 Contraceptives Market to 2017 - Market Overview
3.1 Introduction
3.2 Revenue Forecasts for Contraceptives Market

3.2.1 Revenues
3.2.2 Annual Cost of Usage for Contraceptives
3.2.3 Share of Prescription and OTC Contraceptives

3.3 Drivers and Barriers for Contraceptives Market

3.3.1 Drivers for Contraceptives
3.3.2 Barriers for Contraceptives

4 Contraceptives Market to 2017- Geographical Landscape
4.1 The US

4.1.1 Revenue
4.1.2 Annual Cost of Therapy for Contraceptives

4.2 Top Five Countries of Europe

4.2.1 Revenue
4.2.2 Annual Cost of Therapy for Contraceptives

4.3 Japan

4.3.1 Revenue
4.3.2 Annual Cost of Therapy for Contraceptives

5 Contraceptives Market to 2017 - Therapeutic landscape
5.1 Oral Contraceptives

5.1.1 Introduction
5.1.2 Revenue
5.1.3 Annual Cost of Therapy
5.1.4 Treatment Usage Patterns

5.2 Injectables

5.2.1 Introduction
5.2.2 Revenue
5.2.3 Annual Cost of Therapy

5.2.4 Treatment Usage Patterns
5.3 Topical Contraceptives

5.3.1 Introduction
5.3.2 Revenue
5.3.3 Annual Cost of Therapy
5.3.4 Treatment Usage Patterns

6 Contraceptives Market to 2017 - Devices landscape
6.1 Vaginal Ring

6.1.1 Introduction
6.1.2 Revenue
6.1.3 Geographical Segmentation
6.1.4 Annual Cost of Usage

6.2 Intrauterine Devices

6.2.1 Introduction
6.2.2 Revenue
6.2.3 Copper Intrauterine Device and Hormonal Intrauterine Device Share
6.2.4 Geographical Segmentation
6.2.5 Annual Cost of Usage

6.3 Condoms

6.3.1 Introduction
6.3.2 Revenue
6.3.3 Geographical Segmentation
6.3.4 Annual Cost of Usage

7 Contraceptives Market to 2017 - Pipeline Analysis
7.1 Introduction
7.2 Profiles of Promising Drugs in the Global Contraceptives Market

7.2.1 AG200-15
7.2.2 Yaz Flex
7.2.3 Pill-Plus

8 Contraceptives Market to 2017 - Competitive Landscape
8.1 Market Share Analysis: Contraceptives Market
8.2 Drug Profile of Major Marketed Contraceptives

8.2.1 Yaz/ Yasmin
8.2.2 Mirena
8.2.3 Nuvaring

8.3 Competitive Profiling

8.3.1 Bayer
8.3.2 Johnson & Johnson
8.3.3 Church & Dwight
8.3.4 Merck
8.3.5 Reckitt & Benckiser

9 Contraceptives Market to 2017 - M&A Landscape
9.1 M&A Landscape

9.1.1 M&A Deals by Year
9.1.2 M&A Deals by Value
9.1.3 M&A Deals by Geography
9.1.4 M&A Deals by Deal Type
9.1.5 M&A Deals by Deal Sub-Type

9.2 R&D Licensing Agreements

9.2.1 Deals by Year
9.2.2 Deals by Geography
9.2.3 Deals by Value

9.3 Co-Development Agreements

9.3.1 Deals by Year
9.3.2 Deals by Geography

10 Contraceptives Market to 2017 - Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Research Methodology

10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
10.3.4 Section Methodology
10.3.5 Expert Panel Validation

10.4 Contact Us
10.5 Disclaimer
10.6 Sources
1.1 List of Tables
Table 1: Contraceptives Market, Global, Revenue, ($bn), 2002 - 2010
Table 2: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2010 - 2017
Table 3: Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 5: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 6: Contraceptives Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 7: Contraceptives Market, The US, Revenue, ($bn), 2002 - 2010
Table 8: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2010 - 2017
Table 9: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002 - 2010
Table 10: Contraceptives Market, The US, Annual Cost of Usage, ($), 2010 - 2017
Table 11: Contraceptives Market, Top Five Countries of Europe, Revenue, ($bn), 2002 - 2010
Table 12: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2010 - 2017
Table 13: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002 - 2010
Table 14: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2010 - 2017
Table 15: Contraceptives Market, Japan, Revenue, ($m), 2002 - 2010
Table 16: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2010 - 2017
Table 17: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002 - 2010
Table 18: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2010 - 2017
Table 19: Oral Contraceptives Market, Global, Revenue, ($m), 2002 - 2010
Table 20: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 21: Oral Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 22: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 23: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2010
Table 24: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2010 - 2017
Table 25: Oral Contraceptives Market, Global, Treatment Usage Patterns, (Million), 2002 - 2010
Table 26: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2010 - 2017
Table 27: Injectables Market, Global, Revenue, ($m), 2002 - 2010
Table 28: Injectables Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 29: Injectables Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 30: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 31: Injectables Market, Global, Annual Cost of Therapy, ($), 2002 - 2010
Table 32: Injectables Market, Global, Annual Cost of Therapy, ($), 2010 - 2017
Table 33: Injectables Market, Global, Treatment Usage Patterns, (‘000), 2002 - 2010
Table 34: Injectables Market, Global, Treatment Usage Patterns Forecasts, (‘000), 2010 - 2017
Table 35: Topical Contraceptives Market, Global, Revenue, ($m), 2002 - 2010
Table 36: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 37: Topical Contraceptives Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 38: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 39: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2010
Table 40: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2010 - 2017
Table 41: Topical Contraceptives Market, Global, Treatment Usage Patterns, (‘000), 2002 - 2010
Table 42: Topical Contraceptives Market, Global, Treatment Usage Patterns, (‘000), 2010 - 2017
Table 43: Vaginal Ring Market, Global, Revenue, ($m), 2002 - 2010
Table 44: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 45: Vaginal Ring Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 46: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 47: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 48: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 49: Intrauterine Devices Market, Global, Revenue, ($m), 2002 - 2010
Table 50: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 51: Intrauterine Devices Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 52: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 53: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 54: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 55: Condoms Market, Global, Revenue, ($m), 2002 - 2010
Table 56: Condoms Market, Global, Revenue Forecasts, ($m), 2010 - 2017
Table 57: Condoms Market, Global, Revenue by Geographical Segmentation, ($m), 2002 - 2010
Table 58: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2010 - 2017
Table 59: Condoms Market, Global, Annual Cost of Usage, ($), 2002 - 2010
Table 60: Condoms Market, Global, Annual Cost of Usage, ($), 2010 - 2017
Table 61: Contraceptives Market, Global, Product Pipeline by Phase, 2011
Table 62: Contraceptives Market, Global, Pipeline, Pre-Clinical Stage Molecules, 2011
Table 63: Contraceptives Market, Global, Pipeline, Discovery Stage Molecules, 2011
Table 64: Contraceptives Market, Global, Pipeline, Phase I Molecules, 2011
Table 65: Contraceptives Market, Global, Pipeline, Phase II Molecules, 2011
Table 66: Contraceptives Market, Global, Pipeline, Phase III Molecules, 2011
Table 67: Contraceptives Market, Global, Pipeline, NDA Filed Molecules, 2011
Table 68: Contraceptives Market, Global, Revenues of Major Marketed Contraceptives, ($m), 2010
Table 69: Contraceptives Market, Global, M&A Deals by Value, 2000 - 2011
Table 70: Contraceptives Market, Global, M&A Deals by Geography, 2000 - 2011
Table 71: Contraceptives Market, Global, M&A Deals by Deal Type, 2000 - 2011
Table 72: Contraceptives Market, Global, Deals by Deal Sub-Type, 2000 - 2011
Table 73: Contraceptives Market, Global, Licensing Agreements by Geography, 2004 - 2011
Table 74: Contraceptives Market, Global, Licensing Agreements by Value, 2004 - 2011
1.2 List of Figures
Figure 1: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002 - 2017
Figure 2: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($bn), 2002 - 2017
Figure 3: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002 - 2017
Figure 4: Contraceptives Market, Global, Share of Prescription and OTC Contraceptives, (%), 2010
Figure 5: Contraceptives Market, Global, Drivers and Barriers, 2011
Figure 6: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2002 - 2017
Figure 7: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002 - 2017
Figure 8: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2002 - 2017
Figure 9: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002 - 2017
Figure 10: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2002 - 2017
Figure 11: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002 - 2017
Figure 12: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2002 - 2017
Figure 13: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017
Figure 14: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2017
Figure 15: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2002 - 2017
Figure 16: Injectables Market, Global, Revenue Forecasts, ($m), 2002 - 2017
Figure 17: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017
Figure 18: Injectables Market, Global, Annual Cost of Therapy, ($), 2002 - 2017
Figure 19: Injectables Market, Global, Treatment Usage Patterns Forecasts, (‘000), 2002 - 2017
Figure 20: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2002 - 2017
Figure 21: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017
Figure 22: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002 - 2017
Figure 23: Topical Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (‘000), 2002 - 2017
Figure 24: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2002 - 2017
Figure 25: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017
Figure 26: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002 - 2017
Figure 27: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2002 - 2017
Figure 28: Intrauterine Devices Market, Global, Share of Hormonal and Copper Intrauterine Device, (%), 2010
Figure 29: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017
Figure 30: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002 - 2017
Figure 31: Condoms Market, Global, Revenue Forecasts, ($m), 2002 - 2017
Figure 32: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002 - 2017
Figure 33: Condoms Market, Global, Annual Cost of Usage, ($), 2002 - 2017
Figure 34: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011
Figure 35: Contraceptives Market, Global, Market Share Analysis, (%), 2011
Figure 36: Contraceptives Market, Global, Bayer Company Profile, 2011
Figure 37: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011
Figure 38: Contraceptives Market, Global, Johnson & Johnson Company Profile, 2011
Figure 39: Contraceptives Market, Global, Johnson & Johnson, SWOT Analysis, 2011
Figure 40: Contraceptives Market, Global, Church & Dwight Company Profile, 2011
Figure 41: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011
Figure 42: Contraceptives Market, Global, Merck Company Profile, 2011
Figure 43: Contraceptives Market, Global, Merck, SWOT Analysis, 2011
Figure 44: Contraceptives Market, Global, Reckitt Benckiser Company Profile, 2011
Figure 45: Contraceptives Market, Global, Reckitt Benckiser, SWOT Analysis, 2011
Figure 46: Contraceptives Market, Global, M&A Deals by Year, 2000 - 2011
Figure 47: Contraceptives Market, Global, M&A Deals by Value (%), 2000 - 2011
Figure 48: Contraceptives Market, Global, M&A Deals by Geography (%), 2000 - 2011
Figure 49: Contraceptives Market, Global, M&A Deals by Deal Type (%), 2000 - 2011
Figure 50: Contraceptives Market, Global, Deals by Deal Sub-Type (%), 2000 - 2011
Figure 51: Contraceptives Market, Global, Licensing Agreements by Year, 2004 - 2011
Figure 52: Contraceptives Market, Global, Licensing Agreements by Geography (%), 2004 - 2011
Figure 53: Contraceptives Market, Global, Licensing Agreements by Value (%), 2004 - 2011
Figure 54: Contraceptives Market, Global, Co-Development Agreements by Year, 2006 - 2011

Published By : GBI Research

PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports
Korea Research Reports
Mexico Research Reports
Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports
Singapore Research Reports
Switzerland Research Reports
UK Research Reports
USA Research Reports
UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company